CHICAGO, May 21, 2021 /PRNewswire/ According to the new market research report "Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic
/PRNewswire/ According to the new market research report "Interventional Oncology Market by Product (Radiofrequency, microwave, embolization, guidewires),.
Interventional Oncology Market worth $2.9 billion by 2026 - Exclusive Report by MarketsandMarkets Interventional Oncology Market by Product (Radiofrequency, microwave, embolization, guidewires), Procedure (Thermal, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis), Enduser (Hospital, ASC) - Global Forecast to 2026 , published by MarketsandMarkets, the global market is estimated to be USD 1.9 billion in 2020 and is projected to reach USD 2.9 billion by 2026, at a CAGR of 6.8%.
Browse in-depth TOC on Interventional Oncology Market
183 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164
The increasing prevalence of diseases and disorders, technological advancements, and increased funding and public-private investments are the key factors driving the growth of the market.
Interventional Cardiology Devices Market worth $21.2 billion by 2025 - Exclusive Report by MarketsandMarkets Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2025 , published by MarketsandMarkets, the global Interventional Cardiology Devices Market size is projected to reach USD 21.2 billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9%.
Browse in-depth TOC on Interventional Cardiology Devices Market
179 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548
The Growth in this market is driven mainly by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries.